Both in Pharmaceuticals
Grace Therapeutics vs SCYNEXIS
Over the past year GRCE returned −40.8% and SCYX returned −22.9%; their daily moves had a correlation of 0.02.
GRCE −40.8% SCYX −22.9%Growth of $1, one year, split-adjusted
| Metric | GRCE | SCYX |
|---|---|---|
| Price | $1.84 | $3.94 |
| Market cap | $38.7M | $39.2M |
| Today | +1.66% | +3.41% |
| 1 month | −10.7% | −21.7% |
| 6 months | −21.0% | −47.8% |
| Year to date | −46.8% | −22.1% |
| 1 year | −41.7% | −25.4% |
| Revenue growth (YoY) | — | −82.8% |
| Gross margin | — | 100.0% |
| Net margin | — | 3147.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.0× |
| Net cash | $13.8M | $54.1M |
| Dividend yield | — | — |
| Volatility (60d) | 43.8% | 64.6% |
| Short % of float | 11.2% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).